Delivery Order SPE2DR25D2014-SPE2DR26FZ84Q
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,043.61 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 24, 2025. This firm fixed-price delivery order, awarded on October 23, 2025, with no set-aside designation, represents a competitively awarded transaction for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $36,129.49 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on November 14, 2025, with an ultimate completion date of November 17, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,749.27 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This non-set-aside, competitively awarded contract was executed on October 22, 2025, with an ultimate completion date of October 23, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award utilizes firm fixed pricing under a delivery order contract type, reflecting a relatively small...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,061.39 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, awarded on October 27, 2025, represents a firm fixed-price delivery order with an ultimate completion date of October 28, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded to AmerisourceBergen, a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with a contract ceiling value of $2,392.50. This competitively awarded, non-set-aside delivery order was issued on November 17, 2025, with an ultimate completion date of November 18, 2025, and will be fulfilled at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract operates under firm fixed pricing terms typical of DLA...
- The Defense Logistics Agency awarded a $22,521.04 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger contract vehicle with DLA. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,461.62 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. The contract, which became effective on November 25, 2025, with completion scheduled for November 26, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, served as the prime contractor, drawing from its substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a $27,169.36 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on November 24, 2025, with completion targeted for November 25, 2025. This firm fixed price, non-set-aside delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,017.06 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on December 11, 2025, with an ultimate completion date of December 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $22,421.56 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price, non-set-aside delivery order was awarded on November 24, 2025, with an ultimate completion date of November 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to treat high cholesterol in patients at risk...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ84QDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,991.67 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price, competitively awarded delivery order is scheduled for completion by December 2, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among qualified vendors in the open market. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, and medical supplies to military healthcare programs and other federal health systems worldwide. Repatha, a specialty medication for cholesterol management, represents the type of high-value pharmaceutical products regularly procured through this strategic contract vehicle to support Defense Health Agency operations and broader federal healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.0k | 11/30/25 |